SCHEMBL4249493

SCHEMBL4249493

O=C(O)c1cccc(-c2ccc(C(=O)N3CCCC3)cc2)c1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.73
MAPK1 P28482 2/20 0.73
POLB P06746 3/20 0.60
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
TSHR P16473 2/20 0.58
KMO O15229 1/20 0.57
ERN1 O75460 1/20 0.56
ALDH1A1 P00352 4/20 0.56
GHSR Q92847 1/20 0.55
CCNC P24863 1/20 0.55
CDK8 P49336 1/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
L3MBTL3 Q96JM7 1/20 0.55
USP2 O75604 1/20 0.54
SLC6A7 Q99884 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28104146 0.94 HPGD (0.69) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL4252992 0.92 L3MBTL3 (0.62) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL28504587 0.87 HPGD (0.72) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL4248924 0.87 HPGD (0.73) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL23440313 0.86 HPGD (0.71) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL18397598 0.86 HPGD (0.71) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL29699833 0.86 HPGD (0.71) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL6614562 0.85 HPGD (1.00) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL3456729 0.84 HPGD (0.96) HPGDMAPK1POLBMEN1KMT2A
SCHEMBL3454812 0.84 HPGD (0.96) HPGDMAPK1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104016907-B Amide compound, compositions and application thereof EVOTEC GMBH (DE) 2016-11-30 CN disclosed
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors FLECK ROMAN WOLFGANG 2009-09-10 US disclosed
EP-1960367-A2 SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS Boehringer Ingelheim International GmbH (DE) 2008-08-27 EP disclosed
WO-2007067836-A2 SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227588-A1 Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors EPHX1, EPHX2, EPX HPGD 13/4885MAPK1 3943/4885POLB 1495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.